X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (38) 38
adult (27) 27
infectious diseases (26) 26
hiv infections - drug therapy (25) 25
male (25) 25
female (24) 24
immunology (23) 23
middle aged (22) 22
index medicus (19) 19
hiv (18) 18
virology (18) 18
viral load (17) 17
hiv infections - virology (14) 14
microbiology (14) 14
antiretroviral therapy (13) 13
hiv infections - immunology (13) 13
anti-hiv agents - therapeutic use (11) 11
cd4 lymphocyte count (11) 11
hiv infections - genetics (11) 11
antiretroviral therapy, highly active (10) 10
aids (9) 9
human immunodeficiency virus--hiv (9) 9
aged (8) 8
drug administration schedule (8) 8
antiretroviral drugs (7) 7
highly active antiretroviral therapy (7) 7
hiv infection (7) 7
hiv infections - complications (7) 7
hiv-1 - drug effects (7) 7
medicine (7) 7
multidisciplinary sciences (7) 7
protease inhibitors (7) 7
risk factors (7) 7
active antiretroviral therapy (6) 6
biochemistry (6) 6
drug therapy, combination (6) 6
follow-up studies (6) 6
genotype (6) 6
hiv-1 (6) 6
human immunodeficiency virus (6) 6
mutation (6) 6
phenotype (6) 6
research (6) 6
research article (6) 6
rna (6) 6
science (6) 6
acquired immune deficiency syndrome--aids (5) 5
adolescent (5) 5
antiretrovirals (5) 5
antiviral agents (5) 5
beer (5) 5
care and treatment (5) 5
case-control studies (5) 5
cd8-positive t-lymphocytes - immunology (5) 5
chemistry (5) 5
cohort studies (5) 5
compositions or test papers therefor (5) 5
compositions thereof (5) 5
condition-responsive control in microbiological orenzymological processes (5) 5
culture media (5) 5
drug therapy (5) 5
enzymology (5) 5
genetic predisposition to disease (5) 5
genetics (5) 5
hiv-1 - genetics (5) 5
hiv-1 - immunology (5) 5
hiv-1 - physiology (5) 5
human necessities (5) 5
human-immunodeficiency-virus (5) 5
hygiene (5) 5
infection (5) 5
lipodystrophy (5) 5
measuring or testing processes involving enzymes, nucleicacids or microorganisms (5) 5
medical or veterinary science (5) 5
metallurgy (5) 5
microorganisms or enzymes (5) 5
mutation or genetic engineering (5) 5
polymorphism, single nucleotide (5) 5
preparations for medical, dental, or toilet purposes (5) 5
processes of preparing such compositions (5) 5
propagating, preserving or maintaining microorganisms (5) 5
reverse transcriptase inhibitors - therapeutic use (5) 5
spirits (5) 5
treatment failure (5) 5
treatment outcome (5) 5
vih (5) 5
vinegar (5) 5
wine (5) 5
acquired immune deficiency syndrome (4) 4
anti-hiv agents - administration & dosage (4) 4
anti-hiv agents - adverse effects (4) 4
antiretroviral agents (4) 4
gene expression (4) 4
health aspects (4) 4
hiv infections (4) 4
hiv patients (4) 4
hiv-1 - isolation & purification (4) 4
hiv-1-infected patients (4) 4
hiv/aids (4) 4
individuals (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 09/2014, Volume 9, Issue 9, p. e106360
Journal Article
Global Change Biology, ISSN 1354-1013, 08/2019, Volume 25, Issue 8, pp. 2727 - 2738
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e47725
Background and Aims: This was a safety and efficacy pharmacogenetic study of a previously performed randomized trial which compared the effectiveness of... 
HAPLOTYPE RECONSTRUCTION | VIRUS-INFECTION | SUSTAINED RESPONSE | ANTIVIRAL THERAPY | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PEGYLATED INTERFERON | VIROLOGICAL RESPONSE | INOSINE TRIPHOSPHATASE GENE | INTERFERON PLUS RIBAVIRIN | GENOME-WIDE ASSOCIATION | Interferon-alpha - metabolism | Pharmacogenetics - methods | Hepatitis C - drug therapy | HIV Infections - genetics | Humans | Genotype | Hepatitis C - genetics | Male | Models, Statistical | Polymorphism, Genetic | Genetic Variation | Suppressor of Cytokine Signaling 3 Protein | Phenotype | Gene Expression Regulation, Viral | HIV Infections - complications | Adult | Female | HIV Infections - drug therapy | Hepatitis C - complications | Models, Genetic | Interleukins - biosynthesis | Suppressor of Cytokine Signaling Proteins - biosynthesis | Ribavirin - pharmacology | Medical research | Pharmacogenetics | Anemia | Comorbidity | Genes | Interferon alpha | HIV patients | Biological response modifiers | HIV (Viruses) | Genetic polymorphisms | Virus diseases | Infection | Tumor necrosis factor | Medicine, Experimental | Genetic aspects | Comparative analysis | Drug therapy | Hepatitis C virus | Health aspects | Viruses | Genomes | Infections | Mental depression | Multivariate analysis | Gene polymorphism | Ribavirin | Interleukin 6 | Hepatitis | α-Interferon | CTLA-4 protein | Hepatology | Human immunodeficiency virus--HIV | Gastroenterology | Interleukin 1 | Chi square analysis | Safety | Neutropenia | Thrombocytopenia | Gold | Effectiveness | Statistical analysis | Pharmacology | Regression analysis | Tumor necrosis factor-α | Patients | ITPA gene | Studies | Polymerase chain reaction | Genetic variance | Genotyping | γ-Interferon | Disturbances | Interleukin 10 | Interferon | Hepatitis C | Viral infections | Polymorphism | VIH (Virus) | Genètica humana | Farmacogenètica | Human genetics | HIV | Human immunodeficiency virus
Journal Article
European journal of nutrition, ISSN 1436-6207, 08/2019, pp. 1 - 12
To assess the association between the consumption of non-soy legumes and different subtypes of non-soy legumes and serum uric acid (SUA) or hyperuricemia in... 
Legumes | Soybeans | Hyperuricemia | Beans | Body weight | Models | Regression analysis | Uric acid | Metabolic syndrome | Metabolic disorders | Geriatrics
Journal Article
Journal of visualized experiments : JoVE, ISSN 1940-087X, 01/2019, Issue 143
Atherosclerosis leads to cardiovascular disease (CVD). It is still unclear whether cholesterol-HDL (cHDL) concentration plays a causal role in atherosclerosis... 
atherosclerosis | CELLS | reverse cholesterol transport | apolipoprotein B-depleted serum | MULTIDISCIPLINARY SCIENCES | macrophage | Medicine | HDL | Issue 143 | fluorescence | NBD-cholesterol | HDL-CHOLESTEROL | cholesterol efflux
Journal Article
by Margalida Rotger and Tracy R. Glass and Thomas Junier and Jens Lundgren and James D. Neaton and Estella S. Poloni and Angélique B. van 't Wout and Rubin Lubomirov and Sara Colombo and Raquel Martinez and Andri Rauch and Huldrych F. Günthard and Jacqueline Neuhaus and Deborah Wentworth and Danielle van Manen and Luuk A. Gras and Hanneke Schuitemaker and Laura Albini and Carlo Torti and Lisa P. Jacobson and Xiuhong Li and Lawrence A. Kingsley and Federica Carli and Giovanni Guaraldi and Emily S. Ford and Irini Sereti and Colleen Hadigan and Esteban Martinez and Mireia Arnedo and Lander Egaña-Gorroño and Jose M. Gatell and Matthew Law and Courtney Bendall and Kathy Petoumenos and Jürgen Rockstroh and Jan-Christian Wasmuth and Kabeya Kabamba and Marc Delforge and Stephane De Wit and Florian Berger and Stefan Mauss and Mariana de Paz Sierra and Marcelo Losso and Waldo H. Belloso and Maria Leyes and Antoni Campins and Annalisa Mondi and Andrea De Luca and Ignacio Bernardino and Mónica Barriuso-Iglesias and Ana Torrecilla-Rodriguez and Juan Gonzalez-Garcia and José R. Arribas and Iuri Fanti and Silvia Gel and Jordi Puig and Eugenia Negredo and Mar Gutierrez and Pere Domingo and Julia Fischer and Gerd Fätkenheuer and Carlos Alonso-Villaverde and Alan Macken and James Woo and Tara McGinty and Patrick Mallon and Alexandra Mangili and Sally Skinner and Christine A. Wanke and Peter Reiss and Rainer Weber and Heiner C. Bucher and Jacques Fellay and Amalio Telenti and Philip E. Tarr and MAGNIFICENT Consortium and INSIGHT and Swiss HIV Cohort Study and for the MAGNIFICENT Consortium and the Swiss HIV Cohort Study
Clinical Infectious Diseases, ISSN 1058-4838, 7/2013, Volume 57, Issue 1, pp. 112 - 121
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e47391
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e49834
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0144789
Background and Objectives Obesity and HIV-1/HAART-associated lipodystrophy syndrome (HALS) share clinical, pathological and mechanistic features. Tumor... 
WEAK INDUCER | APOPTOSIS | OBESITY | TWEAK | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | SOLUBLE CD163 | HIV-1-INFECTED PATIENTS | KAPPA-B PATHWAY | UP-REGULATION | SCAVENGER RECEPTOR CD163 | Tumor Necrosis Factors - genetics | Multivariate Analysis | Gene Expression | Cross-Sectional Studies | HIV-Associated Lipodystrophy Syndrome - genetics | HIV-Associated Lipodystrophy Syndrome - diagnosis | Humans | Middle Aged | Tumor Necrosis Factors - blood | HIV-Associated Lipodystrophy Syndrome - blood | Male | Receptors, Cell Surface - blood | Antigens, CD - genetics | Antigens, Differentiation, Myelomonocytic - genetics | Antiretroviral Therapy, Highly Active | Antigens, CD - blood | Cytokine TWEAK | HIV-1 - physiology | Antigens, Differentiation, Myelomonocytic - blood | Adult | Anti-HIV Agents - therapeutic use | Female | HIV-Associated Lipodystrophy Syndrome - drug therapy | Receptors, Cell Surface - genetics | Highly active antiretroviral therapy | Complications and side effects | Cytokines | Causes of | Lipodystrophy | Development and progression | Health aspects | Obesity | Antiretroviral drugs | Cardiovascular disease | Infections | Inflammation | Multivariate analysis | Metabolism | Epidemiology | Patients | Insulin | Serum levels | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Atherosclerosis | Tumor necrosis factor-TNF | Diabetes | Drug therapy | Enzyme-linked immunosorbent assay | Apoptosis | Obesitat | Case studies | Antiretrovirals | Antiretroviral agents | VIH (Virus) | Estudi de casos | HIV-associated lipodystrophy syndrome | Síndrome de lipodistròfia associada a VIH | HIV (Viruses) | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article